Zogenix Inc 's ROA from the fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Zogenix Inc 's ROA in the fourth quarter of 2021?
Zogenix Inc recorded a cumulative net loss of $-227 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on assets (ROA) of -44.03%.

However, within the Healthcare sector 810 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from 4518 to 5210.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Total Assets Change	-53.92 %	-28.21 %	-2.44 %	-5.27 %	146.41 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-227	-360	-304	-239	-209
Return On Assets (TTM)	-44.03 %	-55.14 %	-43.36 %	-33.99 %	-29.42 %
ZGNX's Total Ranking	# 5210	# 4518	# 4416	# 4135	# 4453
Total Assets (TTM) in million	464	492	535	575	1,006
Seq. Total Assets Change	-5.74 %	-8.09 %	-6.91 %	-42.87 %	46.86 %
Seq. Net Income Change	-	-	-	-	-

ZGNX's 5 Years Annual ROA >> Back to ZGNX Management Effectiveness >> Compare ZGNX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 377
Sector	# 811
Overall	# 5092

Return On Assets Statistics
High	Average	Low
13.31 %	-39.43 %	-113.04 %
(Mar 31 2016)		(Dec 31 2013)

Financial Statements
Zogenix Inc 's Assets	$ 464 million	ZGNX's Balance sheet
Zogenix Inc 's Income	$ 62 million	Quarterly ZGNX's Income Statement
ZGNX's Income by Division		See ZGNX's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017
Y / Y Total Assets Change	-53.92 %	142.92 %	-36.11 %	55.25 %	72.77 %
Total Assets in million	464	1,006	414	648	418
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-227	-209	-420	-124	-127
Annual Return On Assets	-49.05 %	-20.81 %	-101.27 %	-19.11 %	-30.37 %

ZGNX's 5 Years Annual ROA >> Back to ZGNX Management Effectiveness >> Compare ZGNX ROA to its Competitors

More Return On Assets Ratios
ZGNX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZGNX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZGNX's Competitors
Subscribers only: Roa for Zogenix Inc 's Suppliers
Subscribers only: Return On Assets for ZGNX's Customers

You may also want to know
ZGNX's Roi	ZGNX's Inventory Turnover Ratio	ZGNX's Growth Rates	ZGNX's Dividend Comparisons
	ZGNX's Profitability Ratios	ZGNX's Asset Turnover Ratio	ZGNX's Dividend Growth
ZGNX's Roe	ZGNX's Valuation Ratios	ZGNX's Financial Strength Ratios	ZGNX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.